L
Lothar Eckes
Researcher at Boehringer Ingelheim
Publications - 5
Citations - 877
Lothar Eckes is an academic researcher from Boehringer Ingelheim. The author has contributed to research in topics: Lacidipine & Ambulatory blood pressure. The author has an hindex of 3, co-authored 5 publications receiving 864 citations.
Papers
More filters
Journal ArticleDOI
Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis Principal Results of the European Lacidipine Study on Atherosclerosis (ELSA), a Randomized, Double-Blind, Long-Term Trial
Alberto Zanchetti,M. Gene Bond,M. Hennig,Albrecht Neiss,Giuseppe Mancia,Cesare Dal Palù,Lennart Hansson,Bruno Magnani,Karl Heinz Rahn,John L. Reid,Jose L. Rodicio,Michel E. Safar,Lothar Eckes,Paolo Rizzini +13 more
TL;DR: The greater efficacy of lacidipine on carotid IMT progression and number of plaques per patient, despite a smaller ambulatory blood pressure reduction, indicates an antiatherosclerotic action of lacIDipine independent of its antihypertensive action.
Journal ArticleDOI
Risk factors associated with alterations in carotid-intima-media thickness in hypertension: baseline data from the European lacidipine study on atherosclerosis
Alberto Zanchetti,Bond Mg,M. Hennig,Neiss A,Giuseppe Mancia,Dal Palù C,L. Hansson,Bruno Magnani,Karl Heinz Rahn,JL Reid,Jose L. Rodicio,M. E. Safar,Lothar Eckes,Ravinetto R +13 more
TL;DR: Analysis of baseline data from the ELSA has shown that there is an extremely marked prevalence of carotid artery wall alterations among mild-to-moderate, middle-aged hypertensive patients, and significant correlations between ultrasound measurements and the following demographic and clinical variables.
Journal ArticleDOI
Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: Further results of the European Lacidipine Study on Atherosclerosis (ELSA)
Alberto Zanchetti,M. Gene Bond,M. Hennig,Rong Tang,Regina Hollweck,Giuseppe Mancia,Lothar Eckes,Dino Micheli +7 more
TL;DR: The relative benefit of lacidipine over atenolol could be measured precisely by reading scans either during the study or at study-end, however, absolute treatment-related changes cannot safely be judged by readings made during a long-term study, unless a longitudinal quality control of readings is performed.
Journal ArticleDOI